New drug aims to fix Chemo-Induced low platelets
NCT ID NCT07185893
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a drug called Romiplostim N01 in 106 cancer patients whose platelets drop due to chemo, radiation, or immunotherapy. The goal is to see if it can safely raise platelet counts better than the current standard treatment. Patients will be randomly assigned to receive either Romiplostim N01 or another drug (Interleukin-11) for up to 14 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Romiplostim N01
- What this could lead to
- If it works, this could offer a new option to manage low platelets in cancer patients, reducing the need for platelet transfusions and treatment delays.
- What could go wrong
- This is an early-stage trial with only 106 participants, so results may not apply to all patients. The drug may not work better than existing treatments and could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a platelet-boosting drug shorten recovery after stem cell transplants?
- Cord blood cells aim to speed platelet recovery in transplant patients
- Platelet transfusions may influence blood vessel health in critically ill patients
- New drug strategy may reduce blood transfusions after organ transplants
- Blood test could predict bleeding risk in cancer patients
- New study tests rapid blood test to prevent bleeding emergencies in pregnancy